Inve India ▾

Bihar Sponge Iron share price & results

Bihar Sponge Iron Ltd

Results to
Jun 2026
Ownership as of
Jun 2026

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue0.00 ₹ crore−100.0% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating marginUnavailable—Operating profit / revenueQuarter to Jun 2026Not in the filed figures for the quarter to jun 2026. No older figure is substituted.
Net profit2.5 ₹ crore+17.0% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity-34.38 %−17.1 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin-0.91 %−3.2 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)-42.68 %−42.7 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Price

₹11.95 −7.72% · −₹1

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −8.6% 1Y

₹10.0₹12.0₹14.0₹16.0Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26

1Y: ₹13.08 on 24 Oct 2025 → ₹11.95. High ₹16.03 (17 Feb 2026), low ₹10.13 (19 Mar 2026).

Previous close
₹12.95
Market cap
₹122 Cr
52-week range
₹10.13 – ₹16.03
One year
−9.61%
Price to earnings (TTM to Jun 2026)
10.44×
Return on equity (TTM to Jun 2026)
-34.38%

Overview

Symbol
NSE:BIHSPONG
Exchange
NSE
Currency
INR

Your own record

Start an Inve Case for Bihar Sponge Iron Ltd

Free account: one company. Everything above stays public.

Write why you follow Bihar Sponge Iron Ltd and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds